Introduction. Synthetic materials have traditionally been used for tissue reconstruction in thoracic surgery. New biomaterials have been tested in other areas of surgery with good results. Non-cross-linked swine dermal collagen prosthesis has been used to reconstruct musculofascial defects in the trunk with low infection and herniation rate.
Introduction
The majority of thoracic wall defects results from surgical resection of malignant tumor during curative or palliative attempts. Those malignant tumors arise from all different anatomic structures of the thoracic wall and consequently vary in pathology and prognosis. Primary chest wall tumors account for only 0.04% of all new cancers diagnosed and 5% of all thoracic neoplasms. 1 Wide en bloc resection and neoadjuvant radiation therapy and/or chemotherapy are the mainstays of treatments for chest wall malignancies. 2 Chest wall resection because of diverse etiologies can cause extensive chest wall defects, which may involve soft and skeletal tissues. As evidenced by the variety of operative techniques and treatment algorithms in the literature, the resulting defect remain a challenge. [3] [4] [5] One major reason for the continued difficulty in reconstruction is the variability in the tumor extirpation and, subsequently, the unpredictable nature of the subsequent chest wall defect.
In a curative setting, the aim of surgical treatment is the resection of the tumor with microscopically negative margins, to improve local control, and to prevent local recurrence. 6 Appropriate oncologic resection should not be compromised because of concern for the resulting thoracic wall defect. Depending on the extent of the malignant tumor, adequate oncologic resection can result in partial-or full-thickness thoracic wall defects. Fullthickness defects, which involve all tissue layers including soft tissue and bony structures, should be reconstructed immediately during the same surgery to protect the subjacent organs and to enable quick recovery. The extent of bony resection often dictates the need for soft-tissue reconstruction and chest wall support. 7, 8 Sufficient chest wall stability, absence of respiratory impairment, adequate tissue coverage, resistance to infections, and satisfactory cosmetics results are important factors to keep in mind during the reconstruction phase.
There are 2 ways to cover deep chest wall defects: prosthetic or biologic mesh and/or soft tissue flaps with excellent blood supply. 9, 10 Synthetic materials combined with soft-tissue transfers, such as muscle flaps, have been employed in chest wall reconstruction for decades. This strategy has been associated with significant morbidity and mortality. 11, 12 Moreover, their use has potential complications such as surgical site infection, mesh extrusion, and formation of adhesions to underlying viscera. 13 The ideal reconstructive material does not exist that restores skeletal integrity with minimal risk, ease of use, or low cost. However, because of the inconclusiveness of available studies, the type of allomaterial and the technique of reconstruction still depend largely on the expertise and preference of the individual surgeon.
Recently, collagen matrixes harvested from human or animal sources and processed for medical use have emerged as an alternative. The implanted matrix undergoes a remodeling process with cellular infiltration, neovascularization, and exchange of extracellular matrix. [14] [15] [16] [17] [18] [19] [20] [21] In the present study, we evaluated the feasibility and the medium-term and long-term results with the use of a non-cross-linked swine dermal collagen prostheses for thoracic wall reconstruction.
Preoperative Evaluation
Preoperative evaluation should be performed properly and in a multidisciplinary manner with pulmonary and cardiac function tests. In particular, patients with chronic obstructive pulmonary disease should be treated preoperatively to optimize pulmonary function before surgery. Postoperatively, patients with cardiac or pulmonary disorders should be treated in the intensive care unit, and early extubation and active respiratory therapy should be the most important treatment goals. Chest X-ray, computed tomography (CT), and magnetic resonance imaging (MRI) can be used as diagnostic tools to assess the imaging appearance of thoracic wall tumors. CT can provide additional information about calcification, bone destruction, and vascularity of the tumor, whereas MRI provides more soft-tissue details. Precise radiological examination with detailed information about tumor location and extent is essential for proper surgical planning and management as well as preoperative histologic evaluation. CT-controlled biopsy and incisional biopsy should be used as suitable modalities of tissue obtainment. Preoperative histologic examination is mandatory, and it should be performed in any lesions suspected to be malignant.
Material and Methods

Study Setting and Design
We retrospectively reviewed the records of all patients who underwent major thoracic wall resection and reconstruction from January 2010 through December 2015 at Papa Giovanni XXIII Hospital, Bergamo, Italy. Eleven patients diagnosed with chest wall tumor were enrolled in the study (Table 1) . Written informed consent was obtained from all patients. The patients were identified from a query of the Section of General Surgery database. After obtaining approval and patient consent waiver from our institutional review board, the medical records were reviewed for patient demographics, previous treatments, indication for operation, type of resection, what was resected, materials used for reconstruction, duration of hospital stay, associated complications (categorized according to Clavien-Dindo classification), 22 the need for postoperative interventions, pulmonary function, and survival. We also reviewed all operative reports to determine the technique of chest wall reconstruction. All patients underwent preoperative and postoperative CT/MRI scans required for tumor evaluation and oncological follow-up and pulmonary function test. Continuous data were reported as mean values ± standard deviation and as median with range. The comparison between the mean values were performed using the unpaired t test. For statistical analysis and graphs, we used GraphPad Prism 7.01.
Characteristics of Biological Implant
Thoracic wall reconstructions were performed using a 1.4-mm-thick, non-cross-linked swine dermal collagen prosthesis, with different dimensions (8 · 14 cm, 10 · 20 cm, 25 · 18 cm, 20 · 30 cm; Protexa, Tecnoss, Giaveno, Italy). In fact, it is the collagen preserved in the integrated extracellular matrix that has a fundamental role in the tissue regeneration, [23] [24] [25] [26] as (1) it acts as a sound substrate for platelet activation and aggregation; (2) it is able to attract and stimulate the differentiation of mesenchymal stem cells in the bone marrow; (3) it increases the levels of proliferation of fibroblasts by 2/3 times; and (4) contact with it promotes the aggregation and subsequent platelet lysis, which is the very first stage of tissue healing.
Patients and Surgical Technique
Indications for surgery were resection of a chest wall tumor. Patient data are listed in Table 1 . Before treatment, all patients had undergone biopsy to determine definite histopathological diagnosis. All tumor surgeries were en bloc resections, which included the biopsy sites. Resections were performed with a minimum margin of 3 to 4 cm for ribs, and soft tissue. Thoracic cavities were drained with 28-F or 32-F chest tubes. Patches were shaped with scissors to match the resected defect with an overlap of approximately 2 cm on all margins to ensure complete coverage. Under tension, the patch was anchored with multiple single-tied coated nonabsorbable polyethylene terephthalate sutures to neighboring ribs and transosseously drilled holes in the adjoining rib stumps ( Figure 1 ). Redon drainages were placed on top and left in place for at least 7 to 10 days. Adjacent muscles, subcutaneous tissue, and skin were mobilized and approximated with running and interrupted sutures. Cutaneous and soft-tissue defect were rebuilt by transposition of myocutaneous flap particularly latissimus dorsi flap and pectoralis major flap ( Figure 1 ). Before incision, a single shot of cefazolin 2 g was administered for perioperative antibiotic prophylaxis. All patients received continuous postoperative analgesia via a peridural catheter. Patients were mobilized without restrictions from postoperative days 1 to 2. Clinical wound assessment, laboratory tests, and radiological imaging were performed according to routine surgical procedures.
Follow-up
Chest wall reconstructions were evaluated during postoperative oncological follow-up visits at 3, 6, 12, and 24 months. The subjective impressions or complaints from the patients were documented. Wound healing and softtissue coverage were examined. Chest wall stability was tested using deep breath maneuvers and coughing tests. The stability was classified as excellent, good, medium, or poor according to the surgical consultant's impression. Pulmonary function was measured using a volume-displacement body plethysmograph. The quality of life was assessed by short form-36 questionnaire. 27 Routine oncological CT or MRI scans were used to evaluate the patches for structural changes and integrity.
Results
Details of surgical procedures, follow-up, and oncological outcomes are listed in Table 2 . Complete resection (R0) and safety margins were confirmed by histopathological examination in all patients. The prosthesis proved to be implantable under tension. The material was pliable but not stretchable, and resulted in immediate stability of thoracic wall. Pediculate muscle flaps were necessary in all 11 patients. The latissimus dorsi flap was used in 9 patients (82%), and the pectoralis major flap was used in 2 (25%) patients.
All 11 patients underwent clinical examination and answered a standardized questionnaire at a mean followup of 2.2 (SD ± 1.6) years and a median of 1.3 (range = 0.74-5.13) years.
Mean duration of surgery was 289 (SD ± 146.7) minutes, the median was 259 (range = 120-680) minutes. The mean and median hospital stay was 10.73 (SD ± 13.02) days and 13 (range = 7-30) days, respectively. The mean and median length of stay in the intensive care unit was 3.09 (SD ± 1.13) days and 3 (range = 2-5) days, respectively. Patients were mechanically ventilated for a mean of 1.2 (SD ± 1) days and a median of 1 (range = 1-3) day. No major postoperative complications were observed. In particular, no early or late respiratory impairment was observed. We observed 1 (9%) pneumonia (Grade 2), 1 atrial fibrillation (9%) (Grade 2), and 3 (27%) wound healing difficulty because of hematoma or infection (Grade 1). The 30-day mortality was 0%, 1-year mortality and 2-year mortality was 27.2%. One patient died for local recurrence, one patient died for myocardial infarction, and one patient died for sepsis secondary to adjuvant chemotherapy. Following chest wall resections, provoking tests caused only minimal movements of the patch area. At 3-month follow-up, the stability was rated as good (n = 10, 90%) and medium (n = 1, 10%). At 6-month follow-up, the stability was rated excellent in 10 (90%) patients and good in one (10%) patient. The mean preoperatively total lung capacity was 101.1 ± 0.5% of the expected value versus 100.1 ± 0.3% of the expected value after 6-month follow-up (P = .12; Figure 2 ). The mean vital capacity was 100.5 ± 0.5% of the expected value before surgery and 99.5 ± 0.2% of the expected value after 6 months postsurgery (P = .05; Figure 3 ). The mean forced expiratory volume in 1 second before operation was 100.1 ± 0.4% of the expected value and 99.4 ± 0.4% of the expected value after 6-month follow-up (P = .16; Figure 4 ). On routine follow-up CT scans at 6, 12, and 24 moths, all implanted patches were identified as intact without bulging, herniation, rupture, or loss of structural integrity.
Quality of Life
The quality of life assessment revealed that 45% (n = 5) of the patients considered their health condition much better than before the operation, 36% (n = 4) found it slight better, and 18% (n = 2) felt no changes. This finding was confirmed by more detailed questions about daily life activity: 36% (n = 4) could be active for a longer duration than before the operation, 36% (n = 4) could be active for the same duration than before the operation, and 27% (n = 3) found their manageable volume of work reduced and restrictions in what kind of work they were able to accomplish.
Discussion
Chest wall reconstruction techniques were first introduced in the 1940s and were biologic in nature. Watson and James 28 described the use of fascia lata grafts for closure of chest wall defects, whereas Maier 29 treated large anterior defects with cutaneous flaps that include the remaining breast. Bisgard and Swenson 30 were the first to use rib grafts as horizontal struts for reconstruction after sternal resection. In 1950, Campbell 31 first introduced the latissimus dorsi muscle as a chest wall reconstruction flap of a full-thickness anterior thorax defect when the muscle was covered immediately with a split-thickness skin graft.
In the treatment of patients requiring chest wall resection, 3 principles of surgical resection should be maintained. 32 First, a sufficient amount of tissue must be resected to dispose all devitalized tissue. Second, with large chest wall resections, the replacement material must restore satisfactory chest wall rigidity to prevent physiologic flail. Third, healthy soft-tissue coverage is essential to seal the pleural space, protect the viscera and great vessels, and prevent infection. Additionally, the breathing biomechanics should not be significantly compromised. A combined multidisciplinary approach with plastic surgeon and critical care specialists provides an acceptable functional result after chest wall resections.
The location and the size of the chest wall defect influences the need for skeletal stabilization. For small defects (less than 5 cm) or those located posteriorly under the scapula above the fourth rib, the skeleton component can be ignored and the defect closed with only soft tissue. For patients undergoing large wall defects (greater than 5 cm), stabilization of the chest wall defect is indicated.
Following its introduction nearly 30 years ago, polytetrafluoroethylene has emerged as the most frequently applied material for chest wall reconstructions. It allows for implantation under tension and results in a durable replacement of bony and soft tissues. Some surgeons even used methyl methacrylate sandwich techniques or large metal prostheses to create sufficient stability in large defects. 11, 12, 33, 34 The widely used nonabsorbable synthetic materials work by a combination of mechanical force and intense inflammatory reaction. 35 The persistent inflammatory response may induce local side effects, such as adhesions, erosions, and fistula formation, particularly when they are placed directly over the viscera. 11, 12, 33, 34, 36, 37 Their lack of tissue incorporation ability could increase the risk of complication in any condition that compromises wound healing response, such as in irradiated fields or in patients on steroids or immunosuppressive drugs or in the presence of bacterial contamination. 38, 39 Because of the limitations of nonabsorbable synthetic meshes and the incidence of chronic and persistent infections, reconstructive surgeons started to explore the use of biologic scaffolds.
The rationale for employing collagen matrix patches in thoracic wall reconstruction is to combine the rigidity and durability of nonabsorbable synthetic materials with a reduced risk of infection. [18] [19] [20] 40 A growing variety of biological collagen matrix meshes is commercially available. Unlike permanently fixated biological materials, this novel generation of materials allows for a remodeling process with neovascularization and complete integration. One limitation in the use of bioprostheses is the significant cost. The cost of the patches can be compensated for by avoiding the need for a second surgical procedure for removing contaminated meshes, prolonged hospital stay for donor site morbidity, and a delay in initial treatment in the presence of gross contamination of original surgical fields. However, in the past few years, some new brands offer biological matrices at more affordable price.
Our positive experiences with respect to strength, durability, and resistance to infection with this type of biological implant for thoracic wall reconstruction are in accordance with experimental and clinical findings of others. 21, [40] [41] [42] Most of the available data stem from the field of abdominal hernia repair. 43, 44 In abdominal hernia surgery, biological materials proved to be superior even to synthetic meshes with an overall success rate of 90%. Only very few reports describe the application of collagen matrix patches in thoracic surgery, 18, 21, [40] [41] [42] and just 4 articles reported the results of the use of non-cross-linked porcine acellular dermal matrices. 18, 19, 42, 45 Barua et al, 46 in 2012, presented their extensive experience with biologic prosthesis in the reconstruction of soft tissues and skeleton in thoracic surgery. They used 2 different materials in their practice: cross-linked porcine dermal collagen matrix and non-cross-linked bovine pericardium. A total of 76 biological patches were used in 44 patients. The prosthesis was mainly used to replace the diaphragm (79.5%), pericardium (75%), and chest wall (14%). Three patients (6.8%) died during the postoperative period, but none of those deaths were related directly to the reconstructive technique used. Surgical complications were seen in 3 (6.8%) patients; 1 patient experienced pulmonary parenchyma bleeding, 1 patient experienced tension pneumothorax, and 1 patient experienced empyema. Overall, with a median follow-up of 11 (range = 1-24) months, they did not see any patch-related complications or infections after the initial postoperative period.
However, no experimental study exists that compares the biomechanical characteristics of collagen matrixes and synthetic materials directly. Holton et al 47 made a comparison of acellular dermal matrix and synthetic mesh for lateral chest wall reconstruction in a rabbit model. They found that implant-fascia interface strength using the biological mesh was significantly stronger than that with synthetic mesh. Moreover, in this study, they observed that the biological mesh causes less adhesion than synthetic mesh because it becomes vascularized and remodeled with host tissue. These last features potentially improve its ability to resist infection and to support secondary wound healing if exposure occurs.
We strongly think that understanding of the host response to implanted materials enable the surgeon to choose the best mesh, with enhanced wound healing properties and fewer graft-related complications. Extracellular matrices have been widely studied on animal models. Most of available data come straight from producers and had not been peer reviewed. Different animals were used as animal models, such as pig, primate, or guinea pig. 48, 49 By fact, the most common animal for use as animal model of incisional hernia has been rat. 50, 51 Mestak et al 50 compared the strength of incorporation and biocompatibility of 2 porcine-derived grafts (cross-linked and non-cross-linked) in a rat hernia model. Both graft materials showed cellular ingrowth and neovascularization by 3 months post implantation. The average level of cellularization and vascularization were significantly higher in the non-cross-linked grafts than in the crosslinked grafts. The maximum load, the breaking strength, and the strength of incorporation of both biomaterials increased during the study period. The study concluded that non-cross-linked grafts may be slightly more biocompatible and allow a more rapid and higher degree of cellular penetration and vascularization, resulting in stronger attachment to the tissues. Another similar study conducted by Ayubi et al 51 compared the cross-linked and non-cross-linked porcine derived grafts in terms of strength of incorporation (SOI), incorporation of host tissue, and adhesion formation using a rat model. The specimens were examined for SOI, neovascularization, collagen deposition, collagen organization, and adhesion formation. The non-cross-linked mesh had significantly greater SOI, collagen deposition, and neovascularization than the cross-linked mesh. The area of adhesions was not significantly different between the 2 biological meshes. Similar results were found in a study conducted by Melman et al 49 in porcine model. Moreover, Mulder et al 52 showed a lower rate of infection in contaminated field with non-cross-linked mesh compared with crosslinked mesh.
To our knowledge, our case series is the biggest report on the use of a non-cross-linked swine dermal collagen prosthesis for thoracic wall reconstruction. Moreover, we report medium-and long-term follow-up, quality of life, and the pulmonary function that showed nonsignificant changes from preoperative to postoperative after thoracic wall resection. The clinical and radiological findings in this study support long-term stability and effective integration of this type of collagen matrix implant.
Of course, our article presents some limitations. It is a retrospective review of a single surgical firm, and there is no control group. We present also a modest sample size that only allows limited conclusions.
However, the desirable outcomes, minimal complications, and patient tolerance suggest that non-cross-linked bioprostheses can provide a safe and effective alternative to other materials for chest wall reconstruction. Further studies are needed to better clarify which type of bioprosthesis has the lowest complications rate and the best longterm results.
